Autosomal dominant Alzheimer's disease: Underlying causes

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Volumn , Issue , 2014, Pages 27-47

  Ghani, Mahdi ^a   Rogaeva, Ekaterina ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Alzheimer's disease; APP; Gene; PLD3; PSEN1; PSEN2; TREM2

Indexed keywords

EID: 84920497801     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4471-6380-0_3     Document Type: Chapter

References (122)

1. Dementia statistics. Available at: http://www.alz.co.uk/research/statistics . Accessed 3 Jan 2014.
2. Miyoshi K. What is 'early onset dementia'? Psychogeriatrics. 2009;9(2):67-72 [Review].
3. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature. 2012;488(7409):96-9.
4. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci. 2003;26:81-104 [Review].
5. Stefanacci RG. The costs of Alzheimer's disease and the value of effective therapies. Am J Manag Care. 2011;17 Suppl 13:S356-62 [Review].
6. Hardy JA, Higgins GA. Alzheimer's disease: The amyloid cascade hypothesis. Science. 1992;256(5054):184-5 [Review].
7. St George-Hyslop PH, Petit A. Molecular biology and genetics of Alzheimer's disease. C R Biol. 2005;328(2):119-30 [Review].
8. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991;349(6311):704-6.
9. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature. 1995;375(6534):754-60.
10. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science. 1995;269(5226):973-7.
11. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature. 1995;376(6543):775-8.
12. Guyant-Marechal L, Campion D, Hannequin D. Alzheimer disease: Autosomal dominant forms. Rev Neurol (Paris). 2009;165(3):223-31.
13. Raber J, Huang Y, Ashford JW. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004;25(5):641-50.
14. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome- wide association study identifi es variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009;41(10):1088-93.
15. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al. Genome-wide association study identifi es variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet. 2009;41(10):1094-9.
16. Carrasquillo MM, Belbin O, Hunter TA, Ma L, Bisceglio GD, Zou F, et al. Replication of CLU, CR1, and PICALM associations with Alzheimer disease. Arch Neurol. 2010;67(8):961-4.
17. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset alzheimer's disease. Nat Genet. 2011;43(5):436-41.
18. Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet. 2011;43(5):429-35.
19. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007;39(2): 168-77.
20. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, et al. Extended meta-analysis of 74, 538 individuals identifi es 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-8.
21. Bignante EA, Heredia F, Morfini G, Lorenzo A. Amyloid beta precursor protein as a molecular target for amyloid beta-induced neuronal degeneration in Alzheimer's disease. Neurobiol Aging. 2013;34:2525-37.
22. Postina R. Activation of alpha-secretase cleavage. J Neurochem. 2012;120 Suppl 1:46-54 [Review].
23. Allinson TM, Parkin ET, Turner AJ, Hooper NM. ADAMs family members as amyloid precursor protein alpha-secretases. J Neurosci Res. 2003;74(3):342-52.
24. Nicolaou M, Song YQ, Sato CA, Orlacchio A, Kawarai T, Medeiros H, et al. Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer's disease. Neurogenetics. 2001;3(4):203-6.
25. Cruts M, Dermaut B, Rademakers R, Roks G, Van den Broeck M, Munteanu G, et al. Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset alzheimer's disease. Neurosci Lett. 2001;313(1-2):105-7.
26. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature. 1992;360(6405):672-4.
27. Wolfe MS. The gamma-secretase complex: membrane-embedded proteolytic ensemble. Biochemistry. 2006;45(26):7931-9 [Review].
28. Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell. 2007;131(2):215-21 [Review].
29. Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell. 1999;97(3):395-406.
30. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, et al. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med. 2000;6(4):397-404.
31. Sisodia SS, St George-Hyslop PH. gamma-Secretase, Notch, Abeta and Alzheimer's disease: Where do the presenilins fit in? Nat Rev Neurosci. 2002;3(4):281-90.
32. Cruts M, Theuns J, Van Broeckhoven C. Locus-specifi c mutation databases for neurodegenerative brain diseases. Hum Mutat. 2012;33(9):1340-4.
33. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science. 1990;248(4959):1124-6.
34. Van Broeckhoven C, Haan J, Bakker E, Hardy JA, Van Hul W, Wehnert A, et al. Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). Science. 1990;248(4959):1120-2.
35. Fernandez-Madrid I, Levy E, Marder K, Frangione B. Codon 618 variant of Alzheimer amyloid gene associated with inherited cerebral hemorrhage. Ann Neurol. 1991;30(5):730-3.
36. Bornebroek M, Haan J, Maat-Schieman ML, Van Duinen SG, Roos RA. Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D): I-A review of clinical, radiologic and genetic aspects. Brain Pathol. 1996;6(2):111-4 [Review].
37. Bugiani O, Giaccone G, Rossi G, Mangieri M, Capobianco R, Morbin M, et al. Hereditary cerebral hemorrhage with amyloidosis associated with the E693K mutation of APP. Arch Neurol. 2010;67(8):987-95.
38. Kamino K, Orr HT, Payami H, Wijsman EM, Alonso ME, Pulst SM, et al. Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region. Am J Hum Genet. 1992;51(5):998-1014.
39. Nilsberth C, Westlind-Danielsson A, Eckman CB, Condron MM, Axelman K, Forsell C, et al. The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofi bril formation. Nat Neurosci. 2001;4(9):887-93.
40. Tomiyama T, Nagata T, Shimada H, Teraoka R, Fukushima A, Kanemitsu H, et al. A new amyloid beta variant favoring oligomerization in Alzheimer's-type dementia. Ann Neurol. 2008;63(3):377-87.
41. Grabowski TJ, Cho HS, Vonsattel JP, Rebeck GW, Greenberg SM. Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol. 2001;49(6):697-705.
42. Greenberg SM, Shin Y, Grabowski TJ, Cooper GE, Rebeck GW, Iglesias S, et al. Hemorrhagic stroke associated with the Iowa amyloid precursor protein mutation. Neurology. 2003;60(6):1020-2.
43. Hendriks L, van Duijn CM, Cras P, Cruts M, Van Hul W, van Harskamp F, et al. Presenile dementia and cerebral haemorrhage linked to a mutation at codon 692 of the beta-amyloid precursor protein gene. Nat Genet. 1992;1(3):218-21.
44. Roks G, Van Harskamp F, De Koning I, Cruts M, De Jonghe C, Kumar-Singh S, et al. Presentation of amyloidosis in carriers of the codon 692 mutation in the amyloid precursor protein gene (APP692). Brain. 2000;123(Pt 10):2130-40.
45. Kumar-Singh S, Cras P, Wang R, Kros JM, van Swieten J, Lubke U, et al. Dense-core senile plaques in the Flemish variant of Alzheimer's disease are vasocentric. Am J Pathol. 2002;161(2):507-20.
46. Rovelet-Lecrux A, Hannequin D, Raux G, Le Meur N, Laquerriere A, Vital A, et al. APP locus duplication causes autosomal dominant early-onset alzheimer disease with cerebral amyloid angiopathy. Nat Genet. 2006;38(1):24-6.
47. Guyant-Marechal I, Berger E, Laquerriere A, Rovelet-Lecrux A, Viennet G, Frebourg T, et al. Intrafamilial diversity of phenotype associated with app duplication. Neurology. 2008;71(23):1925-6.
48. Domingues-Montanari S, Pares M, Hernandez-Guillamon M, Fernandez-Cadenas I, Mendioroz M, Ortega G, et al. No evidence of APP point mutation and locus duplication in individuals with cerebral amyloid angiopathy. Eur J Neurol. 2011;18(10):1279-81.
49. Haass C, Hung AY, Selkoe DJ, Teplow DB. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem. 1994;269(26):17741-8.
50. Kumar-Singh S, De Jonghe C, Cruts M, Kleinert R, Wang R, Mercken M, et al. Nonfi brillar diffuse amyloid deposition due to a gamma(42)-secretase site mutation points to an essential role for N-truncated A beta(42) in Alzheimer's disease. Hum Mol Genet. 2000;9(18): 2589-98.
51. De Jonghe C, Esselens C, Kumar-Singh S, Craessaerts K, Serneels S, Checler F, et al. Pathogenic APP mutations near the gamma-secretase cleavage site differentially affect Abeta secretion and APP C-terminal fragment stability. Hum Mol Genet. 2001;10(16):1665-71.
52. Cruts M, Dermaut B, Rademakers R, Van den Broeck M, Stogbauer F, Van Broeckhoven C. Novel APP mutation V715A associated with presenile Alzheimer's disease in a German family. J Neurol. 2003;250(11):1374-5.
53. Eckman CB, Mehta ND, Crook R, Perez-tur J, Prihar G, Pfeiffer E, et al. A new pathogenic mutation in the APP gene (I716V) increases the relative proportion of A beta 42(43). Hum Mol Genet. 1997;6(12):2087-9.
54. Herl L, Thomas AV, Lill CM, Banks M, Deng A, Jones PB, et al. Mutations in amyloid precursor protein affect its interactions with presenilin/gamma-secretase. Mol Cell Neurosci. 2009;41(2):166-74.
55. Citron M, Vigo-Pelfrey C, Teplow DB, Miller C, Schenk D, Johnston J, et al. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A. 1994;91(25):11993-7.
56. Perez RG, Squazzo SL, Koo EH. Enhanced release of amyloid beta-protein from codon 670/671 "Swedish" mutant beta-amyloid precursor protein occurs in both secretory and endocytic pathways. J Biol Chem. 1996;271(15):9100-7.
57. Kirkitadze MD, Condron MM, Teplow DB. Identifi cation and characterization of key kinetic intermediates in amyloid beta-protein fi brillogenesis. J Mol Biol. 2001;312(5):1103-19.
58. Mullan M, Crawford F, Axelman K, Houlden H, Lilius L, Winblad B, et al. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta- Amyloid. Nat Genet. 1992;1(5):345-7.
59. Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, et al. A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science. 2009;323(5920):1473-7.
60. Ghani M, Sato C, Lee J, Reitz C, Moreno D, Mayeux R, et al. Evidence of recessive Alzheimer's disease loci in Caribbean Hispanics: genome-wide survey of runs of homozygosity. JAMA Neurol. 2013;70(10):1261-7. doi:10.1001/jamaneurol.2013.3545.
61. McNaughton D, Knight W, Guerreiro R, Ryan N, Lowe J, Poulter M, et al. Duplication of amyloid precursor protein (APP), but not prion protein (PRNP) gene is a significant cause of early onset dementia in a large UK series. Neurobiol Aging. 2012;33(2):426.e13-21.
62. Brouwers N, Sleegers K, Engelborghs S, Bogaerts V, Serneels S, Kamali K, et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brain. 2006;129(Pt 11):2984-91.
63. Ghani M, Pinto D, Lee JH, Grinberg Y, Sato C, Moreno D, et al. Genome-wide survey of large rare copy number variants in Alzheimer's disease among Caribbean hispanics. G3 (Bethesda). 2012;2(1):71-8.
64. Hazrati LN, Van Cauwenberghe C, Brooks PL, Brouwers N, Ghani M, Sato C, et al. Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism. Neurobiol Aging. 2012;33(12):2949.e5-12.
65. Hooli BV, Kovacs-Vajna ZM, Mullin K, Blumenthal MA, Mattheisen M, Zhang C, et al. Rare autosomal copy number variations in early-onset familial Alzheimer's disease. Mol Psychiatry. 2013. doi:10.1038/mp.2013.77. [Epub ahead of print].
66. St George-Hyslop P, McLachlan DC, Tsuda T, Rogaev E, Karlinsky H, Lippa CF, et al. Alzheimer's disease and possible gene interaction. Science. 1994;263(5146):537.
67. Wilhelmus MM, Otte-Holler I, Davis J, Van Nostrand WE, de Waal RM, Verbeek MM. Apolipoprotein E genotype regulates amyloid-beta cytotoxicity. J Neurosci. 2005;25(14):3621-7.
68. Schellenberg GD, Bird TD, Wijsman EM, Orr HT, Anderson L, Nemens E, et al. Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. Science. 1992;258(5082):668-71.
69. St George-Hyslop P, Haines J, Rogaev E, Mortilla M, Vaula G, Pericak-Vance M, et al. Genetic evidence for a novel familial Alzheimer's disease locus on chromosome 14. Nat Genet. 1992;2(4):330-4.
70. Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, et al. Genevestigator v3: A reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics. 2008;2008:420747. doi:10.1155/2008/420747 Epub 2008 Jul 8.
71. Haass C, De Strooper B. The presenilins in Alzheimer's disease-proteolysis holds the key. Science. 1999;286(5441):916-9.
72. Yu G, Nishimura M, Arawaka S, Levitan D, Zhang L, Tandon A, et al. Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature. 2000;407(6800):48-54.
73. St George-Hyslop P, Fraser PE. Assembly of the presenilin gamma-/epsilon-secretase complex. J Neurochem. 2012;120 Suppl 1:84-8 [Review].
74. Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T, et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo. Neuron. 1996;17(5):1005-13.
75. Lemere CA, Lopera F, Kosik KS, Lendon CL, Ossa J, Saido TC, et al. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology. Nat Med. 1996;2(10):1146-50.
76. Mann DM, Iwatsubo T, Cairns NJ, Lantos PL, Nochlin D, Sumi SM, et al. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43). Ann Neurol. 1996;40(2):149-56.
77. Mann DM, Iwatsubo T, Nochlin D, Sumi SM, Levy-Lahad E, Bird TD. Amyloid (Abeta) deposition in chromosome 1-linked Alzheimer's disease: The Volga German families. Ann Neurol. 1997;41(1):52-7.
78. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT, Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature. 1999;398(6727):513-7.
79. Fluhrer R, Fukumori A, Martin L, Grammer G, Haug-Kroper M, Klier B, et al. Intramembrane proteolysis of GXGD-type aspartyl proteases is slowed by a familial Alzheimer disease-like mutation. J Biol Chem. 2008;283(44):30121-8.
80. Crook R, Verkkoniemi A, Perez-Tur J, Mehta N, Baker M, Houlden H, et al. A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. Nat Med. 1998;4(4):452-5.
81. Rogaeva EA, Fafel KC, Song YQ, Medeiros H, Sato C, Liang Y, et al. Screening for PS1 mutations in a referral-based series of AD cases: 21 novel mutations. Neurology. 2001;57(4): 621-5.
82. De Jonghe C, Cruts M, Rogaeva EA, Tysoe C, Singleton A, Vanderstichele H, et al. Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased Abeta42 secretion. Hum Mol Genet. 1999;8(8):1529-40.
83. Muller U, Winter P, Graeber MB. A presenilin 1 mutation in the fi rst case of Alzheimer's disease. Lancet Neurol. 2013;12(2):129-30.
84. Benitez BA, Karch CM, Cai Y, Jin SC, Cooper B, Carrell D, et al. The PSEN1, p.E318G Variant Increases the Risk of Alzheimer's Disease in APOE-epsilon4 Carriers. PLoS Genet. 2013;9(8):e1003685.
85. Snider BJ, Norton J, Coats MA, Chakraverty S, Hou CE, Jervis R, et al. Novel presenilin 1 mutation (S170F) causing Alzheimer disease with Lewy bodies in the third decade of life. Arch Neurol. 2005;62(12):1821-30.
86. Yescas P, Huertas-Vazquez A, Villarreal-Molina MT, Rasmussen A, Tusie-Luna MT, Lopez M, et al. Founder effect for the Ala431Glu mutation of the presenilin 1 gene causing earlyonset alzheimer's disease in Mexican families. Neurogenetics. 2006;7(3):195-200.
87. Murrell J, Ghetti B, Cochran E, Macias-Islas MA, Medina L, Varpetian A, et al. The A431E mutation in PSEN1 causing familial Alzheimer's disease originating in Jalisco State, Mexico: An additional fifteen families. Neurogenetics. 2006;7(4):277-9.
88. Athan ES, Williamson J, Ciappa A, Santana V, Romas SN, Lee JH, et al. A founder mutation in presenilin 1 causing early-onset alzheimer disease in unrelated Caribbean Hispanic families. JAMA. 2001;286(18):2257-63.
89. Tang MX, Cross P, Andrews H, Jacobs DM, Small S, Bell K, et al. Incidence of AD in African- Americans, Caribbean Hispanics, and Caucasians in northern Manhattan. Neurology. 2001;56(1):49-56.
90. Rogaeva E. The solved and unsolved mysteries of the genetics of early-onset alzheimer's disease. Neuromolecular Med. 2002;2(1):1-10 [Review].
91. Le TV, Crook R, Hardy J, Dickson DW. Cotton wool plaques in non-familial lateonset alzheimer disease. J Neuropathol Exp Neurol. 2001;60(11):1051-61.
92. Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Namba M, et al. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: A clinicopathological study of four autopsy cases. Acta Neuropathol. 2003;106(4):348-56.
93. Hiltunen M, Helisalmi S, Mannermaa A, Alafuzoff I, Koivisto AM, Lehtovirta M, et al. Identifi cation of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset alzheimer's disease family: An Alu core sequencestimulated recombination? Eur J Hum Genet. 2000;8(4):259-66.
94. Smith MJ, Kwok JB, McLean CA, Kril JJ, Broe GA, Nicholson GA, et al. Variable phenotype of Alzheimer's disease with spastic paraparesis. Ann Neurol. 2001;49(1):125-9.
95. Sinha N, Grimes D, Tokuhiro S, Sato C, Rogaeva E, Woulfe J. Variant Alzheimer's disease with spastic paraparesis and supranuclear gaze palsy. Can J Neurol Sci. 2013;40(2):249-51.
96. Dermaut B, Kumar-Singh S, Engelborghs S, Theuns J, Rademakers R, Saerens J, et al. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann Neurol. 2004;55(5):617-26 [Research Support, Non-U.S. Gov't].
97. Sitek EJ, Narozanska E, Peplonska B, Filipek S, Barczak A, Styczynska M, et al. A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene. PLoS One. 2013;8(4):e61074.
98. Mahoney CJ, Downey LE, Beck J, Liang Y, Mead S, Perry RJ, et al. The Presenilin 1 P264L Mutation Presenting as non-Fluent/Agrammatic Primary Progressive Aphasia. J Alzheimers Dis. 2013;36:239-43.
99. Braga-Neto P, Pedroso JL, Alessi H, de Souza PV, Bertolucci PH, Barsottini OG. Early-onset familial Alzheimer's disease related to presenilin 1 mutation resembling autosomal dominant spinocerebellar ataxia. J Neurol. 2013;260(4):1177-9.
100. Li D, Parks SB, Kushner JD, Nauman D, Burgess D, Ludwigsen S, et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet. 2006;79(6):1030-9.
101. Bernardi L, Tomaino C, Anfossi M, Gallo M, Geracitano S, Costanzo A, et al. Novel PSEN1 and PGRN mutations in early-onset familial frontotemporal dementia. Neurobiol Aging. 2009;30(11):1825-33.
102. Amtul Z, Lewis PA, Piper S, Crook R, Baker M, Findlay K, et al. A presenilin 1 mutation associated with familial frontotemporal dementia inhibits gamma-secretase cleavage of APP and notch. Neurobiol Dis. 2002;9(2):269-73.
103. Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, et al. Mutations in progranulin explain atypical phenotypes with variants in MAPT. Brain. 2006;129(Pt 11): 3124-6.
104. Wang B, Yang W, Wen W, Sun J, Su B, Liu B, et al. Gamma-secretase gene mutations in familialacne inversa. Science. 2010;330(6007):1065.
105. Kimberly WT, Xia W, Rahmati T, Wolfe MS, Selkoe DJ. The transmembrane aspartates in presenilin 1 and 2 are obligatory for gamma-secretase activity and amyloid beta-protein generation. J Biol Chem. 2000;275(5):3173-8.
106. Jayadev S, Case A, Eastman AJ, Nguyen H, Pollak J, Wiley JC, et al. Presenilin 2 is the predominant gamma-secretase in microglia and modulates cytokine release. PLoS One. 2010;5(12):e15743.
107. Li J, Xu M, Zhou H, Ma J, Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell. 1997;90(5):917-27.
108. Bird TD, Levy-Lahad E, Poorkaj P, Sharma V, Nemens E, Lahad A, et al. Wide range in age of onset for chromosome 1-related familial Alzheimer's disease. Ann Neurol. 1996;40(6):932-6.
109. Lao JI, Beyer K, Fernandez-Novoa L, Cacabelos R. A novel mutation in the predicted TM2 domain of the presenilin 2 gene in a Spanish patient with late-onset alzheimer's disease. Neurogenetics. 1998;1(4):293-6.
110. Ezquerra M, Lleo A, Castellvi M, Queralt R, Santacruz P, Pastor P, et al. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early- onset alzheimer disease. Arch Neurol. 2003;60(8):1149-51.
111. Marchani EE, Bird TD, Steinbart EJ, Rosenthal E, Yu CE, Schellenberg GD, et al. Evidence for three loci modifying age-at-onset of Alzheimer's disease in early-onset PSEN2 families. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(5):1031-41.
112. Piscopo P, Marcon G, Piras MR, Crestini A, Campeggi LM, Deiana E, et al. A novel PSEN2 mutation associated with a peculiar phenotype. Neurology. 2008;70(17):1549-54.
113. Lippa CF, Fujiwara H, Mann DM, Giasson B, Baba M, Schmidt ML, et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. Am J Pathol. 1998;153(5):1365-70.
114. Bertram L, Lill CM, Tanzi RE. The genetics of Alzheimer disease: back to the future. Neuron. 2010;68(2):270-81.
115. Kuwano R, Hara N. Personal genomics for Alzheimer's disease. Brain Nerve. 2013;65(3): 235-46.
116. Choi M, Scholl UI, Ji W, Liu T, Tikhonova IR, Zumbo P, et al. Genetic diagnosis by whole exome capture and massively parallel DNA sequencing. Proc Natl Acad Sci U S A. 2009;106(45):19096-101.
117. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, Lee C, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature. 2009;461(7261):272-6.
118. Pruitt KD, Harrow J, Harte RA, Wallin C, Diekhans M, Maglott DR, et al. The consensus coding sequence (CCDS) project: Identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 2009;19(7):1316-23.
119. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer's disease. N Engl J Med. 2013;368(2):117-27.
120. Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A, Wallon D, Rousseau S, et al. High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early- onset alzheimer disease. Mol Psychiatry. 2012;17(9):87-9.
121. Cruchaga C, Karch CM, Jin SC, Benitez BA, Cai Y, Guerreiro R, et al. Rare coding variants in the phospholipase D3 gene confer risk for Alzheimer's disease. Nature. 2014;505(7484): 550-4.
122. MacArthur DG, Tyler-Smith C. Loss-of-function variants in the genomes of healthy humans. Hum Mol Genet. 2011;19(R2):R125-30.